| Clinical status | Total | ||||
|---|---|---|---|---|---|
| Cured | Good | Fair | Poor | ||
| ≧90% | 89-60% | 59-30% | <30% | ||
| Associated immunological disease (p>0.05) | |||||
| Yes | 33(52.4) | 11(17.5) | 7(11.1) | 12(19.0) | 63(100) |
| No | 109(68.6) | 20(12.6) | 14(8.8) | 16(10.1) | 159(100) |
| Total | 142(64.0) | 31(14.0) | 21(9.5) | 28(12.6) | 222(100) |
| Previous Treatments (p>0.05) | |||||
| Yes | 72(59.0) | 21(17.2) | 13(10.7) | 16(13.1) | 122(100) |
| No | 70(70.0) | 10(10.0) | 8(8.0) | 12(12.0) | 100(100) |
| Total | 142(64.0) | 31(14.0) | 21(9.5) | 28(12.6) | 222(100) |
| Family history (p>0.05) | |||||
| Yes | 5(55.6) | 3(33.3) | 1(11.1) | 0 | 9(100) |
| No | 137(64.3) | 28(13.1) | 20(9.4) | 28(13.1) | 213(100) |
| Total | 142(64.0) | 31(14.0) | 21(9.5) | 28(12.6) | 222(100) |
| Relapse (p<0.05) | |||||
| Yes | 30(51.7) | 14(24.1) | 7(12.1) | 7(12.1) | 58(100) |
| No | 112(68.3) | 17(10.4) | 14(8.5) | 21(12.8) | 164(100) |
| Total | 142(64.0) | 31(14.0) | 21(9.5) | 28(12.6) | 222(100) |